Warning letter
ABS Corporation: warning letter of Jul 23, 2026
FDA warning letter 732115 · Center for Veterinary Medicine
Key facts
| Reference number | 732115 |
|---|---|
| Company | ABS Corporation |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Jul 23, 2026 |
| Posted date | Aug 4, 2026 |
| Issuing office | Center for Veterinary Medicine |
| Product type | Veterinary |
| CFR sections cited | 211.34, 211.84(a), 211.84(d), 211.100(a), 211.192 |
| Inspection city | Omaha |
| Inspection ZIP | 68112 |
| Inspection start date | Jan 12, 2026 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: